Dr. Knight is investigating the use of biocompatible nanoparticles as in vivo diagnostic imaging agents. The nanoparticles are targeted to molecular markers of disease and are detectable by imaging methods such as magnetic resonance imaging. It is hoped that disease-specific nanoparticles can be used to carry therapeutic agents as well as being used to provide initial diagnosis and monitoring of the progress of therapy. This work is an outgrowth of Dr. Knight’s work on physiologic imaging using radiotracers.
For more information, please visit Dr. Knight’s website.
Nanotechnology Commercialization in Pennsylvania
“Across the world, the competition to find the next great scientific advancement continues to grow… as a competitor in the global marketplace, it is Pennsylvania’s responsibility to give our universities, companies and partners the best opportunties to be on the forefront of these advancements.”
–The Honorable Edward G. Rendell
Governor of Pennsylvania